These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Relationship between exercise capacity and urinary liver-type fatty acid-binding protein in middle-aged and older individuals. Kosaki K; Kamijo-Ikemori A; Sugaya T; Tanahashi K; Kumagai H; Sawano Y; Akazawa N; Ra SG; Kimura K; Shibagaki Y; Maeda S Clin Exp Nephrol; 2017 Oct; 21(5):810-817. PubMed ID: 28197733 [TBL] [Abstract][Full Text] [Related]
83. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Yokoyama T; Kamijo-Ikemori A; Sugaya T; Hoshino S; Yasuda T; Kimura K Am J Pathol; 2009 Jun; 174(6):2096-106. PubMed ID: 19435794 [TBL] [Abstract][Full Text] [Related]
84. Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury. Tanaka T; Noiri E; Yamamoto T; Sugaya T; Negishi K; Maeda R; Nakamura K; Portilla D; Goto M; Fujita T Nephron Exp Nephrol; 2008; 108(1):e19-26. PubMed ID: 18182783 [TBL] [Abstract][Full Text] [Related]
85. Kidney Disease and the Nexus of Chronic Kidney Disease and Acute Kidney Injury: The Role of Novel Biomarkers as Early and Accurate Diagnostics. Yerramilli M; Farace G; Quinn J; Yerramilli M Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):961-93. PubMed ID: 27485279 [TBL] [Abstract][Full Text] [Related]
86. Relationship between ultrasonographically determined renal dimensions and International Renal Interest Society stages in cats with chronic kidney disease. Yan GY; Chen KY; Wang HC; Ma TY; Chen KS J Vet Intern Med; 2020 Jul; 34(4):1464-1475. PubMed ID: 32585054 [TBL] [Abstract][Full Text] [Related]
87. Symmetric Dimethylarginine: Improving the Diagnosis and Staging of Chronic Kidney Disease in Small Animals. Relford R; Robertson J; Clements C Vet Clin North Am Small Anim Pract; 2016 Nov; 46(6):941-60. PubMed ID: 27499007 [TBL] [Abstract][Full Text] [Related]
88. Evaluation of Gastric pH and Serum Gastrin Concentrations in Cats with Chronic Kidney Disease. Tolbert MK; Olin S; MacLane S; Gould E; Steiner JM; Vaden S; Price J J Vet Intern Med; 2017 Sep; 31(5):1414-1419. PubMed ID: 28833548 [TBL] [Abstract][Full Text] [Related]
89. Comparative effects of benidipine and amlodipine on proteinuria, urinary 8-OHdG, urinary L-FABP, and inflammatory and atherosclerosis markers in early-stage chronic kidney disease. Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Ueda Y; Sugaya T; Yamagishi S; Yamada S; Koide H Am J Med Sci; 2010 Feb; 339(2):157-63. PubMed ID: 20145433 [TBL] [Abstract][Full Text] [Related]
90. Symmetric Dimethylarginine in Cats with Hypertrophic Cardiomyopathy and Diabetes Mellitus. Langhorn R; Kieler IN; Koch J; Christiansen LB; Jessen LR J Vet Intern Med; 2018 Jan; 32(1):57-63. PubMed ID: 29230874 [TBL] [Abstract][Full Text] [Related]
91. Untargeted metabolomic profiling of serum from client-owned cats with early and late-stage chronic kidney disease. Nealon NJ; Summers S; Quimby J; Winston JA Sci Rep; 2024 Feb; 14(1):4755. PubMed ID: 38413739 [TBL] [Abstract][Full Text] [Related]
92. Chemiluminescence Immunoassay Method of Urinary Liver Fatty-acid-binding Protein as a Promising Candidate for Kidney Disease. Niu L; Li L; Li J; Chen Z; Lin J; Zhang B; Fu X J Fluoresc; 2023 May; 33(3):1191-1200. PubMed ID: 36629965 [TBL] [Abstract][Full Text] [Related]
93. Efficacy of oral AB070597 for the management of chronic kidney disease in cats: a prospective, randomised, controlled parallel-group study. Tsunekawa N; Sato M J Feline Med Surg; 2024 Oct; 26(10):1098612X241275249. PubMed ID: 39417648 [TBL] [Abstract][Full Text] [Related]
94. Serum concentrations of gabapentin in cats with chronic kidney disease. Quimby JM; Lorbach SK; Saffire A; Kennedy A; Wittenburg LA; Aarnes TK; Creighton KJ; Jones SE; Paschall RE; King EM; Bruner CE; Wallinger JN; van Haaften KA J Feline Med Surg; 2022 Dec; 24(12):1260-1266. PubMed ID: 35195476 [TBL] [Abstract][Full Text] [Related]
95. Evaluation of Urinary L-FABP as a Tubular Damage Marker in Pediatric Neurogenic Bladder-A Pilot Study. Bagińska J; Kirejczyk JK; Korzeniecka-Kozerska A J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337429 [TBL] [Abstract][Full Text] [Related]
97. Evaluation of platelet function in cats with and without kidney disease: a pilot study. Benson KK; Quimby JM; Shropshire SB; Summers SC; Dowers KL J Feline Med Surg; 2021 Aug; 23(8):715-721. PubMed ID: 33196335 [TBL] [Abstract][Full Text] [Related]
98. Chronic kidney disease - a challenge for the 21st century. Bessant C J Feline Med Surg; 2013 Sep; 15 Suppl 1(1 Suppl):2. PubMed ID: 23999181 [No Abstract] [Full Text] [Related]
99. Detecting antegrade urine flow using detective flow imaging in a cat with chronic kidney disease. Tamura M; Ohta H J Small Anim Pract; 2024 Mar; 65(3):219. PubMed ID: 37905749 [No Abstract] [Full Text] [Related]
100. Use of unbiased metagenomic and transcriptomic analyses to investigate the association between feline calicivirus and feline chronic gingivostomatitis in domestic cats. Fried WA; Soltero-Rivera M; Ramesh A; Lommer MJ; Arzi B; DeRisi JL; Horst JA Am J Vet Res; 2021 May; 82(5):381-394. PubMed ID: 33904799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]